Virtual ISPOR 2020 Begins Next Week

Published May 11, 2020

The Society’s First Virtual Conference Runs May 18-20 With a Preconference COVID-19 Plenary May 14

Virtual ISPOR 2020Lawrenceville, NJ, USA—May 11, 2020—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) confirmed the program today for Virtual ISPOR 2020. The Society is holding its first virtual conference in response to the COVID-19 pandemic. Virtual ISPOR 2020, “HEOR: Advancing Evidence to Action,” will feature sessions that had been planned for the live event that would have been held in Orlando, FL, USA. The virtual conference is offering nearly 60 hours of content that registrants can attend live and/or on demand through June 30, 2020.

Virtual ISPOR 2020 plenary sessions will include:

Plenary 1: Health Policy—Designing For the Future
May 18, 2020  9:00AM - 10:30AM EDT (13:00 - 14:30 UTC)

The World Health Organization reports that one third of the world population lacks access to medicines, vaccines, and other essential health products; threatening lives and risking the emergence of other diseases and health-related effects, such as the antimicrobial resistance. With the growing realization that health is not exclusively a cost issue, rather it is an investment for the future, this multistakeholder panel of experts will share health policy insights from both sides of the Atlantic. Speakers include:

  • Moderator: Dana Goldman, PhD; University of Southern California; Los Angeles, CA, USA
  • Margaret Anderson, MA; Deloitte Consulting LLP; Washington, DC, USA
  • Sir Andrew Dillon; National Institute for Health and Care Excellence; London, England, UK
  • Tomas Philipson, PhD, MA; White House Council of Economic Advisers; Washington, DC, USA

 

Plenary 2: HEOR and Clinical Decision Making—Advancing Meaningful Progress
May 19, 2020  |  12:30PM - 2:00PM EDT (16:30 - 18:00 UTC)
The rise of big data and artificial intelligence bring wide-ranging opportunities for HEOR to become a relevant part of clinical decision making. In this plenary, panelists will explore data-driven, collaborative approaches to clinical decision making and ways that HEOR could strengthen health service delivery and enhance the patient experience.

  • Moderator: Jan Hansen, PhD; Genentech; South San Francisco, CA, USA
  • Marc Boutin, JD; National Health Council; Washington, DC, USA
  • Rachael Callcut, MD, MSPH; University of California, San Francisco Center for Digital Health; San Francisco, CA, USA
  • Nigam Shah, MBBS, PhD; Stanford University; Stanford, CA, USA

 

Plenary 3: On the Road to Enhanced Cost-Effectiveness Analysis—New Directions, New Milestones
May 20, 2020  |  12:00PM - 1:15PM EDT (16:00 - 17:15 UTC)
This plenary session will explore a number of innovative approaches to capture patient and societal values in value assessment frameworks that go beyond the standard cost per quality-adjusted life year (QALY) usage. The expert panel will discuss the underlying methods of these approaches and their potential for use in healthcare decision making. Speakers include:

  • Moderator: Deborah Freund, MA, MPH, PhD; Claremont Graduate University; Claremont, CA, USA
  • Anirban Basu, PhD, MPH; University of Washington; Seattle, WA, USA
  • Susan Griffin, PhD; University of York; York, England, UK
  • Darius Lakdawalla, PhD; University of Southern California; Los Angeles, CA, USA



Complimentary Preconference Plenary: HEOR in the Era of COVID-19

May 14, 2020  |  10:00AM - 12:00PM EDT (14:00 - 16:00 UTC)

An additional preconference session on COVID-19 is being held and will be made available free to both ISPOR members and nonmembers. This session will focus on the rapidly evolving global COVID-19 crisis with panelists discussing HEOR perspectives, insights, and the implications for short-term and long-term healthcare decisions. (This session requires separate registration.) Topics and speakers include:

  • Keynote Address:COVID-19: Accelerating the Evidence to Inform Our Response
    • Mark McClellan, MD, PhD; Director, Duke-Margolis Center for Health Policy, Washington, DC, USA
  • Panel Discussion: COVID-19: A Global Call to Action For Health Economics and Outcomes Researchers
    • Moderator: Jalpa A. Doshi, PhD; University of Pennsylvania, Philadelphia, PA, USA
    • Andrew H. Briggs, MSc, DPhil; London School of Hygiene and Tropical Medicine, London, England, UK
    • Nuria Oliver, PhD; Data-Pop Alliance, Vodafone Institute and ELLIS; Sant Cugat Del Valles, Catalonia, Spain
    • John H. Powers, MD; George Washington University School of Medicine; Rockville, MD, USA
    • Leo Yee-Sin, MPH; National Centre for Infectious Diseases; Singapore

 

In addition to the plenary sessions, Virtual ISPOR 2020 will feature issue panels, workshops, podium presentations, and educational symposia. Research abstracts from the conference will continue to be published in the Society’s journal, Value in Health, and will be available in the ISPOR Presentations Database. The ISPOR Essential HEOR Education Short Course Program will also be offered virtually with a variety of course topics and dates following the conference.

Additional information can be found at: 
Virtual ISPOR 2020 Microsite  |  Program  |  Registration Information  |  Short Courses  |  Press

###

 

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

ISPOR Announces Virtual ISPOR 2020

Apr 6, 2020

ISPOR announced that its annual, international conference has been reimagined due to the COVID-19 pandemic and will now take place as a virtual conference.

ISPOR-FDA Summit 2020 Will Focus on the Use of Patient-Preference Information in Medical Devices

Jan 28, 2020

ISPOR announced that it will be holding a joint ISPOR-FDA Summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” on March 31, 2020 in Silver Spring, MD, USA.

ISPOR Europe 2019 Convened More Than 5500 Healthcare Stakeholders in the Society’s Largest Conference To Date

Nov 7, 2019

ISPOR concluded its ISPOR Europe 2019 conference yesterday in Copenhagen, Denmark. The conference convened more than 5500 global healthcare stakeholders and HEOR thought leaders representing more than 90 countries. The record attendance of ISPOR Europe 2019 marks the Society’s largest conference to date.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×